BNP Paribas Asset Management
IART icon

BNP Paribas Asset Management’s Integra LifeSciences IART Stock Holding History

BNP Paribas Asset Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Sell
767
-829
-52% -$11.6K ﹤0.01% 2138
2026
Q1 		$15K Buy
1,596
+415
+35% +$4.56K ﹤0.01% 2104
2025
Q4 		$15K Buy
+1,181
New +$15.7K ﹤0.01% 2036
2025
Q3 		– Sell
-859
Closed -$11K – 1964
2025
Q2 		$11K Buy
+859
New +$12.5K ﹤0.01% 1735

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BNP Paribas Asset Management's IART Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Integra LifeSciences (IART) stake by 52% in Q2 2026, selling an estimated $11.6K and leaving 767 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

BNP Paribas Asset Management first reported a position in IART in Q2 2025 and has held it in 4 quarters since. The position peaked at $15K in Q1 2026. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • BNP Paribas Asset Management held 767 shares of Integra LifeSciences worth $13.8K as of Q2 2026.
  • BNP Paribas Asset Management sold 829 Integra LifeSciences shares in Q2 2026, an estimated $11.6K.
  • Integra LifeSciences made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2138 holding.
  • BNP Paribas Asset Management first reported a position in Integra LifeSciences in Q2 2025 and has held it in 4 quarters since.
  • BNP Paribas Asset Management's Integra LifeSciences position peaked at $15K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.